NeuroSense Therapeutics (NRSN) Q3 2024 Earnings

Sep 30Confirmed
Q3 2023
Q1 2024
Q2 2024
Q3 2024
-0.35
-0.2
-0.05
0.1

Details

Expected EPS
-0.185
Actual EPS
-0.05
Surprise EPS
0.14
Surprise Percent
+72.97%

Description

⁨NeuroSense Therapeutics⁩ (⁦NRSN⁩) has reported earnings of ⁦-0.05⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts